New molecular subset of pediatric
liver cancer

11 July, 2022

Our partner BCM identified a new molecular subset of pediatric liver cancer. The study showed that these tumors have better outcomes when patients were treated by transplantation, rather than by chemotherapy and surgery alone. Click here for more information.